Breaking News: CYTK – Market Insights, Analysis & Latest Updates

CYTK
SNY

Cytokinetics stock rises on Sanofi's rights acquisition

Cytokinetics shares rose 4.8% after Sanofi announced it will acquire rights to aficamten for Greater China, highlighting growth potential in treating hypertrophic cardiomyopathy.

investing.com • 20/12/2024 - 19:13 PM

BAYRY
CYTK

Bayer acquires rights to Cytokinetics' heart drug in Japan

Bayer collaborates with Cytokinetics to acquire rights to an experimental heart drug in Japan, enhancing its cardiovascular business amid financial challenges.

investing.com • 19/11/2024 - 08:28 AM

Greed and Fear Index

Note: The data is for reference only.

Greed

Cytokinetics stock rises on Sanofi's rights acquisition

Bayer acquires rights to Cytokinetics' heart drug in Japan

Currency